Zonisamide
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
68462-128 -
Package NDC
68462-128-01 -
Package NDC
68462-128-05 -
Application number
ANDA077651 -
SPL ID
c00ccc2d-52c6-4a11-a310-d8db25ca3928 -
SPL set ID
fe15e56e-8b86-4a65-825c-31d37dd81612 -
UNII
459384H98V -
RxCUI
314285 -
RxCUI
403966 -
RxCUI
403967
What the source publishes
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Active ingredients
- Zonisamide
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Zonisamide",
"splId": "c00ccc2d-52c6-4a11-a310-d8db25ca3928",
"labels": [
{
"setId": "fe15e56e-8b86-4a65-825c-31d37dd81612",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fe15e56e-8b86-4a65-825c-31d37dd81612",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fe15e56e-8b86-4a65-825c-31d37dd81612"
}
],
"routes": [
"ORAL"
],
"labeler": "Glenmark Pharmaceuticals Inc., USA",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 CAPSULE in 1 BOTTLE (68462-128-01)",
"package_ndc": "68462-128-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20060130"
},
{
"sample": false,
"description": "500 CAPSULE in 1 BOTTLE (68462-128-05)",
"package_ndc": "68462-128-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20060130"
}
],
"productId": "68462-128_c00ccc2d-52c6-4a11-a310-d8db25ca3928",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "68462-128",
"deaSchedule": null,
"genericName": "Zonisamide",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ZONISAMIDE",
"strength": "25 mg/1"
}
],
"applicationNumber": "ANDA077651",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20060130",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175753",
"N0000008486",
"M0020790",
"N0000000235",
"N0000185503"
],
"upc": [
"0368462130018",
"0368462129012",
"0368462128015"
],
"unii": [
"459384H98V"
],
"rxcui": [
"314285",
"403966",
"403967"
],
"spl_set_id": [
"fe15e56e-8b86-4a65-825c-31d37dd81612"
],
"pharm_class_cs": [
"Sulfonamides [CS]"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"pharm_class_epc": [
"Anti-epileptic Agent [EPC]"
],
"pharm_class_moa": [
"Carbonic Anhydrase Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]"
],
"manufacturer_name": [
"Glenmark Pharmaceuticals Inc., USA"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:68462-128_c00ccc2d-52c6-4a11-a310-d8db25ca3928"